Greenphage

France
Clapiers, Occitanie, France, 34830

Company profile

Greenphage company profile

Greenphage develops bacteriophage-based methods to address bacterial infections and contaminations in human, animal, and plant health. It uses bacteriophages to create alternatives to antibacterial treatments. The company conducts laboratory research on phage studies, molecular virology, and microbiology. It also works with research institutions to support its phage therapy efforts.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2017-01-01, Year

Headquarters

Postal code
34830
Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$2.2M
Last funding
Seed / $2.2M / 2025-07-10
Last equity funding
Seed / $2.2M
Investors
4
Articles
1

Founders and investors

Investors

Environnement Massif CentralIRDI SORIDEC GestionSofilaroSud Mer Invest